Poly Current Deferred Revenue from 2010 to 2024
| POLYMED Stock | 2,582 6.90 0.27% |
Current Deferred Revenue | First Reported 2010-12-31 | Previous Quarter 100.4 M | Current Value 105.4 M | Quarterly Volatility 366.6 M |
Check Poly Medicure financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Poly Medicure's main balance sheet or income statement drivers, such as Depreciation And Amortization of 671.2 M, Interest Expense of 83.2 M or Selling General Administrative of 2.6 B, as well as many indicators such as . Poly financial statements analysis is a perfect complement when working with Poly Medicure Valuation or Volatility modules.
Poly | Current Deferred Revenue |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Poly Stock
Poly Medicure financial ratios help investors to determine whether Poly Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Poly with respect to the benefits of owning Poly Medicure security.